Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
3.335
+0.025 (0.76%)
Jun 26, 2025, 12:13 PM - Market open
Puma Biotechnology Market Cap
Puma Biotechnology has a market cap or net worth of $165.54 million as of June 26, 2025. Its market cap has decreased by -3.59% in one year.
Market Cap
165.54M
Enterprise Value
134.09M
1-Year Change
-3.59%
Ranking
Category
Stock Price
$3.34
Market Cap Chart
Since April 24, 2012, Puma Biotechnology's market cap has decreased from $280.60M to $165.54M, a decrease of -41.00%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 166.80M | 11.42% |
| Dec 31, 2024 | 149.70M | -27.33% |
| Dec 29, 2023 | 206.00M | 6.68% |
| Dec 30, 2022 | 193.10M | 55.35% |
| Dec 31, 2021 | 124.30M | -69.53% |
| Dec 31, 2020 | 408.00M | 19.68% |
| Dec 31, 2019 | 340.90M | -56.07% |
| Dec 31, 2018 | 776.00M | -79.08% |
| Dec 29, 2017 | 3.71B | 228.21% |
| Dec 30, 2016 | 1.13B | -55.55% |
| Dec 31, 2015 | 2.54B | -55.43% |
| Dec 31, 2014 | 5.71B | 92.11% |
| Dec 31, 2013 | 2.97B | 452.60% |
| Dec 31, 2012 | 537.50M | 91.55% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 689.62B |
| Johnson & Johnson | 362.93B |
| Novo Nordisk | 326.28B |
| AbbVie | 325.50B |
| UnitedHealth Group | 272.06B |
| Abbott Laboratories | 231.34B |
| Novartis AG | 229.25B |
| AstraZeneca | 217.06B |